Clinical Trials for Douglas Johnson
1 Open Trial
| Trial Type | Protocol No. & Open Date | Summary |
|---|---|---|
| Epidemiology, Observation, Outcomes | VICCMEL12117 02/18/2013 | A Multi-Site Retrospective Observational Study of US Patients with Unresectable or Metastatic Melanoma Receiving Ipilimumab (YERVOY?) as First-Line Therapy |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
